Hongzhen Li

2.2k total citations
61 papers, 1.6k citations indexed

About

Hongzhen Li is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongzhen Li has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongzhen Li's work include Prostate Cancer Treatment and Research (11 papers), Cancer Cells and Metastasis (9 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Hongzhen Li is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer Cells and Metastasis (9 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Hongzhen Li collaborates with scholars based in United States, China and Germany. Hongzhen Li's co-authors include Shiv Srivastava, Johng S. Rhim, Bungo Furusato, Jun Miki, Yongpeng Gu, David G. McLeod, Isabell A. Sesterhenn, Marja T. Nevalainen, Griffin P. Rodgers and Shinichi Egawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Hongzhen Li

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongzhen Li United States 20 712 639 394 267 182 61 1.6k
Yixing Jiang United States 23 975 1.4× 680 1.1× 366 0.9× 312 1.2× 207 1.1× 81 1.9k
Daniela Hirsch Germany 19 392 0.6× 513 0.8× 198 0.5× 199 0.7× 208 1.1× 57 1.3k
Peizhen Hu China 22 817 1.1× 297 0.5× 316 0.8× 461 1.7× 240 1.3× 55 1.8k
Bingbing Dai United States 28 1.6k 2.2× 590 0.9× 197 0.5× 470 1.8× 269 1.5× 48 2.3k
Takuya Fukazawa Japan 26 1.1k 1.6× 545 0.9× 301 0.8× 364 1.4× 157 0.9× 75 1.8k
Orietta Gandini Italy 23 524 0.7× 878 1.4× 324 0.8× 552 2.1× 142 0.8× 56 1.7k
Kazuo Yashima Japan 24 782 1.1× 626 1.0× 301 0.8× 272 1.0× 87 0.5× 91 2.1k
Dongfeng Qu United States 32 1.0k 1.4× 894 1.4× 202 0.5× 500 1.9× 372 2.0× 57 2.7k
Munenori Takaoka Japan 28 1.3k 1.8× 465 0.7× 245 0.6× 355 1.3× 162 0.9× 80 2.1k

Countries citing papers authored by Hongzhen Li

Since Specialization
Citations

This map shows the geographic impact of Hongzhen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhen Li more than expected).

Fields of papers citing papers by Hongzhen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongzhen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhen Li. The network helps show where Hongzhen Li may publish in the future.

Co-authorship network of co-authors of Hongzhen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hongzhen Li. A scholar is included among the top collaborators of Hongzhen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzhen Li. Hongzhen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Jianqiong, Kyung Chin, Jizhong Zou, et al.. (2025). IFN-γ increases δ-globin gene expression through activation of the JAK/STAT pathway in erythroid cells. Blood. 147(10). 1111–1124.
2.
3.
Liu, Kun, Quan Zhou, Xuan Wang, et al.. (2025). Clinical characteristics of pancreatic cancer presenting with acute pancreatitis: a propensity-matched cohort study. Surgical Endoscopy. 39(5). 3307–3316. 1 indexed citations
4.
5.
Bai, Yun, Xianshu Gao, Shanshi Li, et al.. (2024). Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer. Thoracic Cancer. 16(2). e15514–e15514. 1 indexed citations
6.
Ma, Mingwei, Ke Wang, Xianshu Gao, et al.. (2023). Integration of Multiparameter MRI into Conventional Pretreatment Risk Factors to Predict Positive Surgical Margins After Radical Prostatectomy. Clinical Genitourinary Cancer. 22(2). 281–290.e1. 3 indexed citations
7.
Liu, Yixiao, Bo Jin, Cheng Shen, et al.. (2023). Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients. Frontiers in Oncology. 13. 1086517–1086517. 3 indexed citations
8.
Li, Hongzhen, Chunyan Peng, Xiwei Ding, et al.. (2022). PPARγ/SOD2 Protects Against Mitochondrial ROS-Dependent Apoptosis via Inhibiting ATG4D-Mediated Mitophagy to Promote Pancreatic Cancer Proliferation. Frontiers in Cell and Developmental Biology. 9. 745554–745554. 15 indexed citations
9.
Li, Hongzhen, Xianshu Gao, Dong Fang, et al.. (2022). Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 40(9). 410.e1–410.e10. 2 indexed citations
10.
Ma, Mingwei, Xianshu Gao, Xiaobin Gu, et al.. (2020). Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients. World Journal of Urology. 39(6). 1815–1823. 3 indexed citations
11.
Cui, Ming, Xiaobin Gu, Dong Fang, et al.. (2020). Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma. World Journal of Surgical Oncology. 18(1). 114–114. 27 indexed citations
12.
Gao, Xianshu, Hongzhen Li, Chao‐Xing Liu, et al.. (2019). <p>Intra-rectal use of epinephrine in radiotherapy of prostate cancer</p>. Cancer Management and Research. Volume 11. 4847–4854. 2 indexed citations
13.
Li, Hongzhen, Christine Kim, Wenli Liu, et al.. (2019). Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. International Journal of Cancer. 146(5). 1346–1358. 9 indexed citations
14.
Zhang, Min, Bo Zhao, Jinpeng Yin, et al.. (2017). Application of new three-dimensional printed tissue compensators in radiotherapy. Zhonghua fangshe zhongliuxue zazhi. 26(2). 210–214. 1 indexed citations
15.
Li, Hongzhen, Xianshu Gao, Ji Chen, et al.. (2015). Relationship between prostate volume reduction and neoadjuvant hormone therapy duration in prostate cancer radiotherapy. Zhonghua fangshe zhongliuxue zazhi. 24(5). 511–515. 1 indexed citations
16.
Wang, Qingguo, Xiaomei Li, Min Zhang, et al.. (2014). [Effect of two dose fractionations on postoperative radiotherapy of keloid: an analysis of 107 patients].. PubMed. 46(1). 169–72. 3 indexed citations
17.
Wang, Youwei, Zhibo Han, Zhibo Han, et al.. (2011). A Toxicity Study of Multiple-Administration Human Umbilical Cord Mesenchymal Stem Cells in Cynomolgus Monkeys. Stem Cells and Development. 21(9). 1401–1408. 63 indexed citations
18.
Li, Hongzhen, et al.. (2009). Synthesis of polyethyleneimine-microcrystalline cellulose and its adsorption character for bilirubin.. Linchan huaxue yu gongye. 29(5). 99–103. 1 indexed citations
19.
Li, Hongzhen. (2008). Surfactivity of the Bolaform Surfactant Disodium Sulfodehydroabietate. Linchan huaxue yu gongye. 1 indexed citations
20.
Gu, Yongpeng, Hongzhen Li, Jun Miki, et al.. (2006). Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. Experimental Cell Research. 312(6). 831–843. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yixing Jiang Breakdown of academic impact, for papers by Daniela Hirsch Breakdown of academic impact, for papers by Peizhen Hu Breakdown of academic impact, for papers by Bingbing Dai Breakdown of academic impact, for papers by Takuya Fukazawa Breakdown of academic impact, for papers by Orietta Gandini Breakdown of academic impact, for papers by Kazuo Yashima Breakdown of academic impact, for papers by Dongfeng Qu Breakdown of academic impact, for papers by Munenori Takaoka
Rankless by CCL
2026